Funding Goes to Cancer Drug Developers, Company Billed as the Anti-Theranos

November 24, 2019


Seeking and destroying lung cancer. Succeeding where Theranos failed. Treating resistant breast cancers. These are the aims of three San Diego biotechs that recently received funding


Leave a Reply

Your email address will not be published. Required fields are marked *